Investor Presentaiton
Citadel Group | Investor Presentation | 8
0
◇ Four key verticals
For personal use only
Clients / Market
Growth Plan
Products
Software
FY20 Revenue $47.5m, GP $29.6m, GP Margin 62.3%
Health (Rev $26.8m, GP $21.2m,
GP Margin 79.1%)
> Public Health Sector
> Private Health Sector
Enterprise (Rev $20.7m, GP
$8.4m, GP Margin 40.6%)
> All levels of government (Federal,
State and Local)
> Large regulated enterprise
Services
FY20 Revenue $80.1m, GP $25.4m, GP Margin 31.7%
Technology (Rev $31.0m, GP
$8.8m, GP Margin 28.4%)
> Tertiary Education
> All levels of government (Federal,
State and Local)
> Large enterprise
> Health
Professional Services
(Rev $49.1m, GP $16.6m, GP
Margin 33.8%)
> Defence
> All levels of government (Federal,
State and Local)
> Large enterprise
> Product Sales and
Installation (including
design and architecture)
> Managed services
> AV AssistⓇ
> Managed services
> Consulting and professional
services
> Partnership with Lean-IX
> Software
Pathology (Auslab™M/
Evolution™)
Oncology/Cancer Care
(CHARM®)
Radiology (CRISⓇ)
Maternity (Euroking)
> International expansion for
pathology and oncology/cancer
care into the UK market
TM
> Software
KapishⓇ
Citadel-IX
AusTender™
Grant Connect T
-
-
goTRIM Pro
TM
TM
> Development of channel
partnerships
> Growth from increased
opportunities in the construction
sector
> Product expansion with
existing customers
> Further penetration into
large enterprise clientsView entire presentation